MANGOCEUTICALS, INC.

MGRX

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
MGRX
CIK0001938046
SIC8090
SectorServices
Industry CategoryHealthcare
Industry GroupServices – Health

Contact

Address15110 DALLAS PKWY, SUITE 600, DALLAS, TX, 75248
Website www.mangorx.com
Phone(833) 626-4679
CEOJacob D. Cohen
EmployeesN/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$511,084.00
Pre-Tax Income$-11.18 million
Net Income$-11.18 million
Net Income to Common$-11.18 million
EPS$-2.43
View All
Balance Sheet
Cash$76,496.00
Assets$21.75 million
Liabilities$1.50 million
Common Equity$20.25 million
Liabilities & Equity$21.75 million
View All
Cash Flow Statement
Calculations
NOPAT$-7.32 million
EBITDA$-11.16 million
Price to EarningsN/A
Price to Book$0.93
ROE-115.89%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Mangoceuticals shares results from field studies on MGX-0024

Mangoceuticals (MGRX) shares results from field studies based on its patented antiviral compound which it refers to as “MGX-0024”. The field studies were conducted by Solice International at Duraiswamy Farm in Palladam, Tamil Nadu, India. These studies, targeting respiratory diseases in chickens, like Newcastle Disease and Chronic Respiratory Disease, CRD, showed MGX-0024, delivered through drinking water, achieved 100% survival against respiratory illnesses in a large-scale trial, offering a pr

Article Link

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to share groundbreaking results from field studies based on its patented antiviral compound which it refers to as “MGX-0024”. The field studies were c

Article Link

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“Mangoceuticals” or “MGRX”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, is pleased to announce that it has entered into an Intellectual Property Purchase Agreement to acquire all intellectual property, product formulations, know-how, distribution, supplier relationships and related asse

Article Link

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

MIAMI, FL / ACCESS Newswire / April 24, 2025 / For decades, the men's health space has remained largely stagnant-held back by legacy brands offering generic solutions and treatment protocols that too often felt like quick fixes rather than genuine ...

Article Link

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent ...

Article Link